StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ATR.L$719.00+1.55%
Fair $719.00+0.0%

ATR.L

Schroder Asian Total Return Inv. Company

Unknown / UnknownLSE

$719.00

+11.00 (+1.55%)

Fairly Valued+0.0%Fair Value $719.00Fund rank 26/100 · Data gapFallback financials|
SA 37/D
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $7.4M · quality 30.0/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 42/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

37/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · ATR.LLocal privado en este navegador · Schroder Asian Total Return Inv. Company
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$669M

P/E

10.4x

↑

EV/EBITDA

N/A

•

ROE

12.1%

↑

Gross Margin

N/A

•

Debt/Equity

N/A

•
52-Week Range$719
$453$723

TradingView lightweight chart

ATR.L price, volumen y niveles de valoración

Último $719.00Periodo +514.5%
Fair value: $719.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

-28.4%

FCF margin

6.1%

FCF / Net income

0.06x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $66.6M · net income $64.1M · FCF $4.0M

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

96.3%-4.6% pts

FCF margin

6.1%+21.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$66.6M$66.6M$58.5M$37.7M$-70.3M
Net Income$64.1M$64.1M$55.6M$35.4M$-70.9M
EPS0.690.690.580.35-0.66
Net Margin96.3%96.3%95.1%93.9%100.9%
Balance Sheet
Debt/Equity——0.060.080.10
Cash Flow
Free Cash Flow$4.0M$4.0M$7.4M$10.9M$11.0M
Returns
ROE12.1%12.1%11.7%7.9%-15.5%
Valuation
P/E10.4210.42829.901228.68—
P/B127.01127.0196.9696.9299.16
Growth & Yield
Revenue Growth13.8%13.8%55.3%153.6%—
EPS Growth17.6%17.6%68.6%152.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

353.1%

muy exigente

EPS terminal req.

$63.80

Spread vs growth

-335.6%

5Y implied EPS CAGR

157.2%

muy exigente

EPS terminal req.

$77.20

Spread vs growth

-139.6%

10Y implied EPS CAGR

68.2%

muy exigente

EPS terminal req.

$124.33

Spread vs growth

-50.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +55.3%

Total return

+55.3%

Start / end P/E

793.9x → 1048.6x

EPS bridge

0.58 → 0.69

Residual

+5.6%

EPS growth+17.6%
Multiple rerating+32.1%
Dividend+0.0%
Residual / FX / buybacks / cross-term+5.6%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.